Alector Statistics
NASDAQ: ALECHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.99+0.065 (+3.39%)
Market open · Delayed 15 min · as of Oct 8, 2:01 PM ET
Alector by the numbers
Alector has a market capitalization of $221.6 million based on 111.66M shares outstanding. With trailing EPS of $-1.09, Alector is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.7% below its 50-day average and 0.8% below its 200-day average.
Average daily trading volume is 2.77M shares, or about $5.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALEC valuation vs. peer median
| Metric | ALEC | Peer median | Difference |
|---|---|---|---|
| Market cap | $221.64M | $213.22M | +4% |
| Avg. volume | 2.77M | 1.31M | +112% |
Peer median across 8 companies: PLX, IVVD, CGEN, IPSC, PALI, FATE, DTIL, CMPX.
Valuation
- Market cap
- $221.64M
- EPS (TTM)
- $-1.09
- Shares outstanding
- 111.66M
Price and trading
- Previous close
- 1.92
- Open
- 1.90
- Day range
- 1.89 – 2.01
- 52-week range
- 1.09 – 3.40
- 52-week change
- -37.46%
- Beta
- —
- Volume
- 1.94M
- Average volume
- 2.77M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 221.64M
- Forward Pe
- -2.71
- Eps
- -1.09
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.40
- Week52 Low
- 1.09
- Avg Volume
- 2.77M
- Shares Outstanding
- 111.66M
- Ma50
- 2.04
- Ma200
- 2.00
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -41.62%
- Pct From52w Low
- 82.11%